Valuation AB Science Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:02:32 2026-08-05 EDT			5-day change	1st Jan Change
0.6430 ^EUR	+5.93%		-5.44%	-52.86%

07-13	AB Science to Discontinue Three Masitinib-related Clinical Studies	MT
07-10	AB Science streamlines its portfolio and refocuses on two molecules

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	332.2	180.9	57.55	112	56.17	-	-
Change	-	-45.55%	-68.19%	94.7%	-49.87%	-	-
Enterprise Value (EV)	332.2	180.9	57.55	112	56.17	56.17	56.17
Change	-	-45.55%	-68.19%	94.7%	-49.87%	0%	0%
P/E	-24.4x	-17.8x	-5.88x	-	-	-	-
PBR	-	-	-	-	-	-	-
PEG	-	0.6x	0.2x	-	-	-	-
Capitalization / Revenue	-	187x	53.7x	95.4x	46.8x	43.2x	35.1x
EV / Revenue	-	0x	0x	0x	46.8x	43.2x	35.1x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	-	-0x	-0x	0x	-8.64x	-8.78x	-
EV / FCF	-	-0x	-	-0x	-8.78x	-15.6x	-14.4x
FCF Yield	-	-9.52%	-	-4.08%	-11.4%	-6.41%	-6.94%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.29	-0.2	-0.15	-	-	-	-
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	-	0.97	1.072	1.174	1.2	1.3	1.6
EBITDA	-	-11.16	-5.416	-	-	-	-
EBIT ¹	-	-13.43	-6.083	0.639	-6.5	-6.4	-
Net income	-13.62	-10.05	-7.831	-	-	-	-
Net Debt	-	-	-	-	-	-	-
Reference price ²	7.0900	3.5550	0.8820	1.5360	0.7020	0.7020	0.7020
Nbr of stocks (in thousands)	46,861	50,891	65,248	72,947	80,015	-	-
Announcement Date	3/1/23	5/15/24	5/13/25	5/13/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MERCK & CO., INC.	29.28x	5.36x	22.26x	2.65%	316B
MERCK KGAA	24.88x	3.38x	11.92x	1.6%	73.28B
HALOZYME THERAPEUTICS, INC.	12.48x	6.33x	9.65x	-	9.87B
KYOWA KIRIN CO., LTD.	15.86x	1.99x	6.75x	2.85%	8.15B
SK BIOPHARMACEUTICALS CO., LTD.	21.29x	6.02x	17.05x	-.--%	4.38B
YUHAN CORPORATION	36.73x	2.34x	27.37x	0.75%	3.91B
BETTA PHARMACEUTICALS CO., LTD.	31.1x	5.92x	16.92x	-	3.62B
SUPERNUS PHARMACEUTICALS, INC.	-135.16x	-	-	-.--%	2.51B
Average	4.56x	4.48x	15.99x	1.31%	52.73B
Weighted average by Cap.	26.88x	4.95x	19.80x	2.41%